LESLIE HARRY: Open Payments
NPI 1477576932 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,390 in 107 payments from 39 companies in 2025. Trend: 2023 $85 · 2024 $339 · 2025 $2,390
Food & beverage: $2,085Education: $305
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $239 |
| GlaxoSmithKline, LLC. | 7 | $148 |
| SEAGEN INC. | 2 | $140 |
| ABBVIE INC. | 5 | $137 |
| Incyte Corporation | 4 | $121 |
| GENZYME CORPORATION | 5 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $114 |
| Daiichi Sankyo Inc. | 4 | $109 |
| Janssen Biotech, Inc. | 6 | $102 |
| Exelixis Inc. | 1 | $100 |
Products named: OJJAARA, SCEMBLIX, Epkinly, KISQALI, KEYTRUDA, MONOFERRIC, IMBRUVICA, POTELIGEO.
Industry payments across PA — which companies pay providers there.
